Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease
Observational · No treatment assigned · Sites not listed yet · Brigham and Women's Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease (IBD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- adults (age 18 years or older)
- clinical diagnosis of ulcerative colitis or Crohn's disease
- \- adults (age 18 years or older) in good health conditions
There are also 11 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 100 participants are expected to take part.
- Start date: 2026-08-01 (planned).
- Main results expected around 2027-09-30 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Skin blood perfusion (1 day)
In the researchers’ words
Acupuncture points or acupoints are fundamental to the practice of acupuncture, yet their scientific basis remains unclear. According to traditional explanations of acupuncture, acupoints can become tender or more sensitive to pressure when there is an underlying disease of the body.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | Brigham and Women's Hospital |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) |
| Enrollment | 100 (estimated) |
| Start date | 2026-08-01 |
| Primary completion (est.) | 2027-09-30 |
| First posted | 2026-07-02 |
| Last updated | 2026-07-02 |
| Official title | Acupoint Sensitization in Inflammatory Bowel Disease: A Non-interventional Study |
| ClinicalTrials.gov ID | NCT07681895 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria (Adults with IBD): * adults (age 18 years or older) * clinical diagnosis of ulcerative colitis or Crohn's disease Exclusion Criteria (Adults with IBD): * any history of serious musculoskeletal or soft tissue injury of the lower and/or upper extremities * presence of scarring or tattoo on the lower and/or upper extremities * presence of serious cardiac diseases, severe dermatological conditions, peripheral neuropathy, infectious disease, psychological illnesses, or other serious co-morbidities (e.g., cancer) * prior history of colostomy or ileostomy * pregnancy Inclusion Criteria (Healthy control participants): \- adults (age 18 years or older) in good health conditions Exclusion Criteria (Healthy control participants): * history of chronic inflammatory diseases, such as IBD * severe digestive and/or intestinal conditions, such as irritable bowel syndrome (IBS) * any history of serious musculoskeletal or soft tissue injury of the lower and/or upper extremities * presence of scarring or tattoo on the lower and/or upper extremities * presence of serious cardiac diseases, severe dermatological conditions, peripheral neuropathy, infectious disease, psychological illnesses, or other serious co-morbidities (e.g., cancer) * pregnancy
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.